Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05670782 · ClinicalTrials.gov registry record · Phase 2

A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease

A Phase 2 study of Parkinson Disease, sponsored by FAScinate Therapeutics.

Active
Registry status
Phase 2
Development phase
314
Enrollment target
3
Study locations

NCT05670782 is a Phase 2 study of Parkinson Disease that is active but no longer recruiting, run by FAScinate Therapeutics. The registered enrollment target is 314 participants, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05670782, a Phase 2 study of Parkinson Disease, is active but no longer recruiting, sponsored by FAScinate Therapeutics.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
314 participants
Enrollment target
3
Study locations

Study Summary

The goal of this study is to test KM-819 in halting or slowing the progression of Parkinson's disease. The study evaluates the safety and tolerability of multiple ascending doses of KM-819 in healthy older adults and participants with Parkinson's disease.

Conditions Studied

Parkinson Disease

Interventions

  • DRUG Placebo
  • DRUG KM-819

Study Locations (3)

California

  • Parexel Early Phase Clinical Unit - Glendale
  • University California San Diego Medical Center - San Diego

Michigan

  • Quest Research Institute, Rose Cancer Center - Royal Oak

Trial Details

FieldValue
Enrollment Target 314 participants
Start Date 2022-07-19
Est. Completion 2025-11-13
Phase Phase 2

Sponsor

FAScinate Therapeutics

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05670782

The ClinicalTrials.gov registry entry for NCT05670782 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (94% lower). The listed sponsor is FAScinate Therapeutics, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05670782 reports 3 study locations spanning 2 distinct geographic areas - top geographies include California, Michigan.

Frequently Asked Questions

What is clinical trial NCT05670782 about?

NCT05670782 is a clinical study titled "A Study to Evaluate Safety and Efficacy of KM-819 in Healthy Adults and Participants with Parkinson's Disease". The goal of this study is to test KM-819 in halting or slowing the progression of Parkinson's disease. The study evaluates the safety and tolerability of multiple ascending doses of KM-819 in healthy older adults and participants with Parkinson's disease.

What is the current status of trial NCT05670782?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 314 participants. The study started on 2022-07-19. Estimated completion is 2025-11-13.

What conditions does trial NCT05670782 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05670782?

The interventions under investigation include: Placebo (DRUG), KM-819 (DRUG).

Who is sponsoring clinical trial NCT05670782?

This trial is sponsored by FAScinate Therapeutics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05670782 being conducted?

This trial has 3 study locations across California, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.